ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

FDBK Feedback Plc

60.50
0.00 (0.00%)
19 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Feedback Plc LSE:FDBK London Ordinary Share GB00BJN59X09 ORD 50P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 60.50 60.00 61.00 60.50 60.50 60.50 14,770 07:44:37
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Electronic Computers 1.03M -2.92M -0.2188 -2.77 8.07M
Feedback Plc is listed in the Electronic Computers sector of the London Stock Exchange with ticker FDBK. The last closing price for Feedback was 60.50p. Over the last year, Feedback shares have traded in a share price range of 58.00p to 150.00p.

Feedback currently has 13,334,659 shares in issue. The market capitalisation of Feedback is £8.07 million. Feedback has a price to earnings ratio (PE ratio) of -2.77.

Feedback Share Discussion Threads

Showing 7726 to 7748 of 14875 messages
Chat Pages: Latest  319  318  317  316  315  314  313  312  311  310  309  308  Older
DateSubjectAuthorDiscuss
08/1/2020
19:06
One extreme to the other bob. Personally I believe they were on the cusp of a big deal with Texrad. It could still happen. In the meantime we hope that Bleepa is indeed the future of NHS communications.
ducatiman
08/1/2020
18:49
Hi Ged, news always welcome even if it doesn’t move markets. We are in a waiting game again and it would be nice to know the strategy when/if the trials deliver the results expected. Is any work being done overseas or in other industries? Until we get news that drives the share price north of 2p it is hard to get too excited...and what about TexRAD it shouldn’t just be allowed to wither. Little clarity at present I’m afraid.
bobd29
08/1/2020
14:05
Such influence Bob! :))

The #Bleepa team are hard at work on plans for revolutionising healthcare in 2020 including our first pilot in @OldhamCO_NHS @NCAlliance_NHS

ged5
07/1/2020
15:02
Afternoon Ged, yes an update would be very welcome. Communication would go a long way towards keeping shareholders happy.
bobd29
07/1/2020
09:23
Good morning Bob. TexRAD seems to have been around a long time and I would like to see them get some value out of it. Others seem to be catching FDBK up. I'm not sure how tight past agreements have been. Stonechecker, Imaging Endpoints, GE Healthcare, what value are we getting? Perhaps the company could inform us.

I wasn't here when AR made that statement so I don't recall. Good with words not so sure about the substance. He's now gone but we still haven't had an announcement since 19th November 2019.

Let's hope the words of TO have more substance. If they do we should have an exciting few years. We could do with some sort of update about the trial, new agreements and CE mark.

ged5
06/1/2020
18:28
Thanks Ged, must have passed me by. Begs the question...if we are not going to focus on commercialising a clinical version, or further develop the programme beyond Lung, then why not sell TexRAD in order to fully focus on Bleepa? Many lths will disagree but if this toddler is ever to become a big fish (remember AR’s famous statement upon his appointment?) then income growth will be paramount. Just musing.....
bobd29
06/1/2020
14:17
Good afternoon Bob and thank you for getting us back on track.

Just looking at the official announcements the most apt are this one from 17th October 2019 and the second one from the AGM statement.

The Company continues to progress with its strategic review of TexRAD®, a longstanding part of the Feedback portfolio. The Company hopes to complete the strategic review by the end of the calendar year.



"We have made some product modifications to TexRAD Research in response to customer feedback and are evaluating the impact of these on revenue. In the near term, we will continue to sell TexRAD within the research setting through third party distributors which provides a more cost-effective avenue for maintaining our sales efforts. As a result, we have reduced the resources associated with TexRAD. These changes also allow us to redirect our efforts and focus onto BleepaⓇ, which we believe holds the largest mid-term revenue opportunity for the Company. We will continue to assess opportunities for the TexRAD platform and will update the market as appropriate."

ged5
06/1/2020
13:02
Afternoon all, am I right in thinking we were promised a full TexRAD review a couple of months after the initial strategic review shortly following TO’s appointment? I seem to think it was due in Sept/Oct? Wonder what happened? Bleepa may have stolen the limelight but where is the TexRAD review?
bobd29
06/1/2020
12:13
Yes Ducatiman it was an interesting blend. I normally do salmon with a chili ginger sauce from the Hairy Bikers diet book but we had some chorizo left from our New Year's Eve starter - Scallops and chorizo.

No Yump, too nice to drop! :))

I'll have to try that LR2.

Meanwhile very little interest today.

ged5
04/1/2020
12:17
I often have mussels and chorizo but have never tried salmon and chorizo. Must find a recipe for it.
lr2
04/1/2020
10:58
Well I’ve heard of name dropping but is that food dropping ?!
yump
03/1/2020
21:21
.98 Ged. Stock taken in at .953. Couldn’t sell diddely squat at .98 today. Salmon and chorizo! Interesting blend. Bon appetite.
ducatiman
03/1/2020
21:02
I saw the .99 trade. Wasn't there just one?

Anyway I found a link to the video that was in the header that works. I had to do something. We were having a quiet salmon and chorizo meal with a glass or two of Sauvignon Blanc when my son phoned to talk about his forthcoming wedding.

No alarms this time.

ged5
03/1/2020
19:50
Couple of mates rates buys today I reckon.
ducatiman
03/1/2020
10:01
Probably best to remove it.

Am getting 'Your connection is not private' message followed by

'Attackers might be trying to steal your information from www.turing-gateway.cam.ac.uk (for example, passwords, messages, or credit cards). Learn more'

NET::ERR_CERT_DATE_INVALID

lr2
03/1/2020
09:37
Thanks for that, LR2. It has relevance to me living in that area.

It does annoy me though seeing others getting this commercial success.

I just checked the link in the header to remind myself of what we read over a year ago.

"Textural Analysis for the Prediction of Cerebrovascular Events"

It didn't work for me saying my clock was misconfigured. If anyone else gets a warning message please let me know and I'll remove the link.

Pity it showed how Textural Analysis detects warning signs in the brain.

ged5
02/1/2020
17:55
I'm not declaring that I'm uninformed but it was an interesting part to his answer. I haven't seen a CEO endorse another company's product before so that for me was quite something. I'm not sure that he was suggesting Bleepa was AI.

You're quite right to point out that Bleepa is not AI. It was derived from Cadran which was PACS.

TexRAD is the AI product and could/should have been used in many different areas by now although I understand it is best applied to lung applications.

Hope your son is OK, Davydoo and Social Services are not involved! ;))

ged5
02/1/2020
17:10
Davydoo, with a couple of 100 per centers thrown in :-)
ducatiman
02/1/2020
16:34
I'd take that comment from GB, although interesting for the uninformed, with a pinch of salt as he lumped it in with an answer about AI, which I raised as a potentially useful and very wide-ranging aid to all sorts of diagnoses, if it were formed in a single source for consultants and GP's.

Bleepa, however brilliant it turns out to be, or not, is not AI - its just a clever individual app.

To some people, everything new is game-changing ;-)

yump
02/1/2020
15:52
for 2020 i'll take 1% up per day
davydoo
02/1/2020
15:15
Happy new year to you too Ged. I thought that Texrad would have made a breakthrough before now. CRUK early detection award, cost savings, more efficient, faster. Maybe it will make an impact soon. Good to read Bleepa being hailed as "game changing".
ducatiman
02/1/2020
12:51
Item coming up shortly on BBC news 24, AI better at detecting breast cancer. Could be worth watching but we already know that don't we?
ducatiman
02/1/2020
12:12
Took my son for an X Ray today, my wife who works in Veterinary medicine wanted to see the xray so i took a photo of the monitor

Wouldn't it have been great to ask them to send it her Bleepa

davydoo
Chat Pages: Latest  319  318  317  316  315  314  313  312  311  310  309  308  Older

Your Recent History

Delayed Upgrade Clock